UCB’s licensing deal with China’s Antengene follows rising global demand for Chinese-developed drug candidates ...

Loughborough University is collaborating with Northumbria University and the Football Supporters’ Association on the Safer Stadiums research initiative, which aims to improve safety and inclusivity ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

The first phase is expected to include housing and office space, but the exact mix remains in flux. The project could also include a hotel.

Company’s anticipated pivotal clinical trial in Hypoplastic Left Heart Syndrome (HLHS) priced at the market under Nasdaq ...

(NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it has received final ...

The South Jersey biotech also secured a $22 million ARPA-H grant and additional investment to advance its research on therapies targeting aging.